Spreadex Market Update

Heavy dollar hit for Johnson & Johnson doesn’t bode well for Dow’s earnings season




The Dow opened around 20 points lower, with Johnson & Johnson’s third quarter results the only thing on offer. Those results didn’t bode well for the rest of the index’s components, with the strong dollar reducing the consumer giant’s revenue by 8.2% to $17.1 billion; news, however, that the company would buyback $10 billion in shares mitigated its losses when the bell rang on Wall Street, with Johnson & Johnson only falling around a percent. Twitter, meanwhile, jumped 5% after a statement from CEO Jack Dorsey that it would be cutting its workforce by 8%.

The continued support of SABMiller, which has held onto its 9%, 330 point increase from the moment the ‘in principle’ Anheuser-Busch InBev news was announced this morning, alongside a 3% jump for Shire after its drug cinryze got FDA fast track status for kidney transplants, meant the FTSE could shrink its losses to around 25 points. Still, the UK index couldn’t quite get them to disappear, with this morning’s pesky plunge in Chinese imports ensuring a limp day from its commodity stocks.

The DAX, on the other hand, couldn’t relinquish its 3 digit decline, the weight of its disastrous ZEW economic sentiment figure, and a further fall from the giant thorn in its side that is Volkswagen, putting investors off of the German index for the entire day.

DISCLAIMER


Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.

Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.

No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.

The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.